Neuland Laboratories Ltd
NSE:NEULANDLAB
Neuland Laboratories Ltd
NSE:NEULANDLAB
Price:
12 300
INR
-5.96%
Market Closed
Market Cap:
157.8B
INR
Balance Sheet
Balance Sheet Decomposition
Neuland Laboratories Ltd
Neuland Laboratories Ltd
| Current Assets | 9.7B |
| Cash & Short-Term Investments | 2B |
| Receivables | 3.1B |
| Other Current Assets | 4.6B |
| Non-Current Assets | 9.8B |
| Long-Term Investments | 106.7m |
| PP&E | 6.7B |
| Intangibles | 2.8B |
| Other Non-Current Assets | 152.9m |
Balance Sheet
Neuland Laboratories Ltd
Neuland Laboratories Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8
|
70
|
34
|
33
|
79
|
112
|
24
|
51
|
454
|
1 646
|
|
| Cash |
8
|
70
|
34
|
33
|
79
|
112
|
24
|
51
|
454
|
876
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
771
|
|
| Short-Term Investments |
0
|
0
|
75
|
75
|
75
|
432
|
233
|
185
|
136
|
291
|
|
| Total Receivables |
1 898
|
1 618
|
2 055
|
2 318
|
2 010
|
2 253
|
2 558
|
2 689
|
3 967
|
4 269
|
|
| Accounts Receivables |
1 288
|
1 277
|
1 812
|
1 952
|
1 658
|
1 920
|
2 207
|
2 632
|
3 912
|
4 198
|
|
| Other Receivables |
610
|
341
|
243
|
366
|
352
|
333
|
351
|
57
|
56
|
71
|
|
| Inventory |
1 134
|
1 427
|
1 460
|
1 857
|
2 013
|
2 285
|
2 607
|
2 802
|
2 945
|
3 662
|
|
| Other Current Assets |
118
|
107
|
126
|
189
|
357
|
70
|
73
|
81
|
107
|
114
|
|
| Total Current Assets |
3 158
|
3 223
|
3 750
|
4 472
|
4 535
|
5 152
|
5 496
|
5 808
|
7 609
|
9 211
|
|
| PP&E Net |
1 638
|
1 894
|
1 746
|
2 899
|
3 349
|
3 651
|
4 312
|
4 866
|
4 980
|
5 686
|
|
| PP&E Gross |
1 638
|
1 894
|
1 746
|
2 899
|
3 349
|
3 651
|
4 312
|
4 866
|
4 980
|
5 686
|
|
| Accumulated Depreciation |
1 388
|
0
|
185
|
371
|
615
|
883
|
1 219
|
1 595
|
2 049
|
2 568
|
|
| Intangible Assets |
8
|
5
|
13
|
18
|
18
|
20
|
35
|
21
|
13
|
25
|
|
| Goodwill |
0
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
|
| Note Receivable |
238
|
142
|
219
|
198
|
274
|
358
|
506
|
85
|
125
|
320
|
|
| Long-Term Investments |
74
|
104
|
333
|
333
|
333
|
335
|
193
|
202
|
199
|
203
|
|
| Other Long-Term Assets |
0
|
6
|
0
|
0
|
0
|
0
|
89
|
59
|
77
|
86
|
|
| Other Assets |
0
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
2 795
|
|
| Total Assets |
5 115
N/A
|
8 168
+60%
|
8 856
+8%
|
10 714
+21%
|
11 304
+6%
|
12 310
+9%
|
13 248
+8%
|
13 835
+4%
|
15 798
+14%
|
18 326
+16%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 118
|
865
|
859
|
1 243
|
1 223
|
1 156
|
1 521
|
1 174
|
1 710
|
1 920
|
|
| Accrued Liabilities |
76
|
79
|
79
|
80
|
86
|
226
|
446
|
415
|
591
|
1 011
|
|
| Short-Term Debt |
1 458
|
1 236
|
1 511
|
1 992
|
1 491
|
1 682
|
570
|
922
|
112
|
0
|
|
| Current Portion of Long-Term Debt |
87
|
130
|
112
|
165
|
217
|
156
|
276
|
371
|
392
|
413
|
|
| Other Current Liabilities |
212
|
418
|
295
|
189
|
253
|
357
|
872
|
749
|
1 585
|
934
|
|
| Total Current Liabilities |
2 951
|
2 728
|
2 856
|
3 669
|
3 270
|
3 576
|
3 685
|
3 632
|
4 390
|
4 277
|
|
| Long-Term Debt |
332
|
332
|
298
|
1 035
|
607
|
800
|
977
|
1 112
|
781
|
541
|
|
| Deferred Income Tax |
124
|
26
|
151
|
128
|
112
|
478
|
598
|
567
|
583
|
604
|
|
| Minority Interest |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
91
|
83
|
95
|
302
|
322
|
357
|
123
|
119
|
103
|
76
|
|
| Total Liabilities |
3 502
N/A
|
3 169
-10%
|
3 400
+7%
|
5 134
+51%
|
4 310
-16%
|
5 210
+21%
|
5 383
+3%
|
5 430
+1%
|
5 857
+8%
|
5 499
-6%
|
|
| Equity | |||||||||||
| Common Stock |
90
|
90
|
90
|
90
|
129
|
129
|
129
|
129
|
129
|
129
|
|
| Retained Earnings |
853
|
4 236
|
4 693
|
4 813
|
1 869
|
1 980
|
2 761
|
3 361
|
4 932
|
7 804
|
|
| Additional Paid In Capital |
663
|
663
|
664
|
664
|
4 978
|
4 978
|
4 978
|
4 978
|
4 978
|
4 978
|
|
| Unrealized Security Profit/Loss |
8
|
9
|
13
|
13
|
13
|
12
|
3
|
27
|
61
|
53
|
|
| Other Equity |
0
|
1
|
3
|
1
|
4
|
0
|
6
|
35
|
36
|
31
|
|
| Total Equity |
1 614
N/A
|
4 999
+210%
|
5 456
+9%
|
5 580
+2%
|
6 993
+25%
|
7 100
+2%
|
7 865
+11%
|
8 405
+7%
|
9 941
+18%
|
12 827
+29%
|
|
| Total Liabilities & Equity |
5 115
N/A
|
8 168
+60%
|
8 856
+8%
|
10 714
+21%
|
11 304
+6%
|
12 310
+9%
|
13 248
+8%
|
13 835
+4%
|
15 798
+14%
|
18 326
+16%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
9
|
13
|
13
|
13
|
13
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
